1 INTRODUCTION By now, metabolic dysfunction-associated steatotic liver disease (MASLD), formerly referred to as non-alcoholic fatty liver disease (NAFLD), is thought to be the most prevalent liver disease worldwide.1 With numbers still increasing, results of epidemiological studies suggest that ~38% of the general population worldwide are affected by MASLD.1 Somewhat in contrast to the hypothesis that nutrition is only critical in the development through a general overnutrition, the number...
